Evidence map›Paper›PMID 16470227›Full record

ArticleEMBO reports2006

Type A and B RNase P RNAs are interchangeable in vivo despite substantial biophysical differences.

Barbara Wegscheid, Ciarán Condon, Roland K Hartmann

Abstract read
In one paragraph

Article in EMBO reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Suppression of theRNA (New York, N.Y.) · 2024
    Article
  2. Article
  3. Bacterial ribonucleases and their roles in RNA metabolism.Critical reviews in biochemistry and molecular biology · 2019
    Review
  4. Article
  5. Bacterial transfer RNAs.FEMS microbiology reviews · 2015
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Barbara WegscheidInstitut für Pharmazeutische Chemie, Philipps-Universität Marburg, Germany.
Ciarán Condon
Roland K Hartmann
Philipps University of Marburg · DEInstitut de Biologie Physico-Chimique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We show that structural type A and B bacterial ribonuclease P (RNase P) RNAs can fully replace each other in vivo despite the many reported differences in their biogenesis, biochemical/biophysical properties and enzyme function in vitro. Our findings suggest that many of the reported idiosyncrasies of type A and B enzymes either do not reflect the in vivo situation or are not crucial for RNase P function in vivo, at least under standard growth conditions. The discrimination of mature tRNA by RNase P, so far thought to prevent product inhibition of the enzyme in the presence of a large cellular excess of mature tRNA relative to the precursor form, is apparently not crucial for RNase P function in vivo.

Indexed as

Bacillus subtilisBase SequenceCell ProliferationEscherichia coliHoloenzymesMolecular Sequence DataMutationNucleic Acid ConformationRecombinant ProteinsRibonuclease PRNA, BacterialTranscription, GeneticHoloenzymesRecombinant ProteinsRibonuclease PRNA, Bacterial

Identifiers

PMID16470227
PMCPMC1456918
OpenAlexW2137478476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.